Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ArcticZymes Technologies Director's Dealing 2020

Feb 12, 2020

3538_dirs_2020-02-12_6e2f6e96-89b9-4563-a807-209428cabcfe.html

Director's Dealing

Open in viewer

Opens in your device viewer

Biotec Pharmacon - Mandatory notification of trade

Biotec Pharmacon - Mandatory notification of trade

(Tromsø 12. February 2020) Volker Wedershoven, board member and primary insider

of Biotec Pharmacon has purchased 40.000 shares in Biotec Pharmacon at NOK 7.99

per share. After this transaction holds Mr. Wedershoven 80.000 shares and 0

options in Biotec Pharmacon ASA.

For further information, please contact

Børge Sørvoll

CFO

+47 952 90 187

[email protected]